Breast Lesions and Carcinomas
Breast Lesions and Carcinomas is a research topic within Pathology and Forensic Medicine. Science Explorer counts 29k research works in it since 1950. 10.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers covers advancements in breast pathology, imaging techniques, and diagnostic procedures. It includes topics such as breast cancer screening, mammography, ultrasound, histological analysis of breast lesions, and the management of specific breast conditions like metaplastic carcinoma and phyllodes tumors.
- Breast Cancer
- Mammography
- Ultrasound
- Pathology
- Lesions
- Biopsy
- Metaplastic Carcinoma
- Phyllodes Tumors
- Atypical Hyperplasia
- Granulomatous Mastitis
- Research works
- 29k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 10.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +9% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Breast Lesions and Carcinomas research?
By volume, the United States and China publish the most (882 and 775 works in 2022–2025).
By volume, 2022–2025
- 1 United States 882 works
- 2 China 775 works
- 3 India 397 works
- 4 United Kingdom 211 works
- 5 Japan 194 works
- 6 Türkiye 149 works
- 7 Italy 147 works
- 8 South Korea 145 works
- 9 Germany 116 works
- 10 Spain 101 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Breast Lesions and Carcinomas research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Breast Lesions and Carcinomas research, followed by Memorial Sloan Kettering Cancer Center and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 33 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 33 works
- 3 All India Institute of Medical SciencesIndia 22 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 5 Sağlık Bilimleri ÜniversitesiTürkiye 16 works
- 6 Institute of Medical SciencesIndia 15 works
- 7 University of North Carolina at Chapel HillUnited States 14 works
- 8 Sun Yat-sen UniversityChina 13 works
- 9 Cleveland ClinicUnited States 13 works
- 10 Fudan University Shanghai Cancer CenterChina 13 works
Who are the leading researchers in Breast Lesions and Carcinomas?
The most-cited researchers publishing on Breast Lesions and Carcinomas include Mike Clarke and Charles M. Perou.
- 1 Mike Clarke United Kingdom 7.5k citations
- 2 Charles M. Perou United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Breast Lesions and Carcinomas research done?
The largest centres of Breast Lesions and Carcinomas research in 2022–2025 are Beijing (China), Seoul (South Korea), Shanghai (China) and New York (United States).
Largest cities, 2022–2025
Where is the best place to study Breast Lesions and Carcinomas?
Among universities, judged by research, University of California, San Francisco, Sri Ramachandra Institute of Higher Education and Research and Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of California, San FranciscoUnited States | 49.4 | 24.8% | 4.2× | 12 | +30.4% |
| 2 | Sri Ramachandra Institute of Higher Education and ResearchIndia | 49.1 | 4.1% | 16.4× | 12 | +173.1% |
| 3 | Institute of Medical SciencesIndia | 44.5 | 0.0% | 10.8× | 15 | +121.2% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 43.9 | 13.2% | 4.9× | 20 | +20.1% |
| 5 | All India Institute of Medical SciencesIndia | 41.9 | 1.7% | 8.3× | 22 | +47.0% |
| 6 | Sungkyunkwan UniversitySouth Korea | 35.7 | 17.2% | 4.2× | 10 | -12.5% |
| 7 | Sağlık Bilimleri ÜniversitesiTürkiye | 34.2 | 0.6% | 6.5× | 16 | — |
| 8 | Sichuan UniversityChina | 33.6 | 13.6% | 1.6× | 12 | +115.4% |
| 9 | Harvard UniversityUnited States | 32.9 | 16.1% | 2.0× | 11 | +11.6% |
| 10 | Istanbul UniversityTürkiye | 32.8 | 4.0% | 5.1× | 8 | +218.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Breast Lesions and Carcinomas research growing?
Output in 2018–2022 was 9% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Breast Lesions and Carcinomas.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.